They put all your stats into a nomogram which then predicts outcomes; you could ask whether your meds team uses it. The best known one is the Memorial Sloan Kettering version but it is American and they tend to have better outcomes than we do here in the UK. We were at St James in Leeds and they have adapted the MSK nomogram to reflect the results of recent years in Leeds and West Yorks. Results in the North East will be slightly worse than USA as well, I should think - it is all linked to socioeconomic groups, educational outcomes, local industry, statistics for men accessing health services, etc. Are you at the RVI?
When John was diagnosed, the urologist did it while we were sitting there and showed us that the outcomes for radiotherapy and surgery were likely to be the same but that John had a 55% likelihood of recurrence. That was also included in his diagnosis letter so we queried it (thinking it was a typo and meant to say 5%) but they confirmed it. John was in a tizz and didn’t really engage with anything he was told - didn’t believe he would have ED, didn’t believe it could come back, surgery was going to cure him and everything would get back to normal ... you get the picture? So he rushed into it and had the op. The nomogram was right; he had seminal vesicle invasion and bladder invasion, a biochemical recurrence and ended up with salvage RT/HT 2 years later. That was nearly 6 years ago though and he bumbles along at 0.1 and tends not to think about his prostate except at PSA testing time so it isn’t all doom and gloom at all.
You could ask the doctor the questions I suggested earlier plus whether they use a nomogram perhaps? And especially, clarify whether the comment he made about lymph node involvement was a red herring or was it confirmed in the scans?